Skip to main content
    C

    Cytosorbents Crp (CTSO)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $3.00
    -0.09 (-2.91%)

    Market Cap: $10.90M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(20/39)
    Avg Surprise
    -17.13%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.90
    Range$-1.00 - $-0.80
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.70-28.6%
    60d ago$-0.70-28.6%
    30d ago$-0.70-28.6%
    7d ago$-0.900.0%
    Current$-0.90
    Revenue Consensus
    $10M
    Range$10M - $10M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-3.40
    Range$-3.40 - $-3.40
    2 analysts
    Revenue Consensus
    $10M
    Range$10M - $11M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-3.40---
    Sep 26EST
    		-$-0.90---
    Jun 26
    Reported Aug 6
    		$-0.07$-0.05-40.00%Miss-40.0%
    Mar 26
    Reported May 13
    		$-0.08$-0.05-60.00%Miss-300.0%
    Dec 25
    Reported Mar 25
    		$-0.09$-0.04-104.08%Miss+35.7%
    Sep 25
    Reported Nov 13
    		$-0.05$-0.05+0.00%Beat+37.5%
    Jun 25
    Reported Aug 7
    		$-0.05$-0.07+28.57%Beat+37.5%
    Mar 25
    Reported May 14
    		$-0.02N/A+71.43%Beat+83.3%
    Dec 24
    Reported Mar 31
    		$-0.14$-0.05-162.66%Miss-7.7%
    Sep 24
    Reported Nov 7
    		$-0.08$-0.06-33.33%Miss+61.9%
    Jun 24
    Reported Aug 13
    		$-0.08$-0.10+20.00%Beat+42.9%
    Mar 24
    Reported May 9
    		$-0.12$-0.12+0.00%Beat+29.4%
    Dec 23
    Reported Mar 14
    		$-0.13$-0.14+7.14%Beat-1200.0%
    Sep 23
    Reported Nov 9
    		$-0.21$-0.12-75.00%Miss+25.0%
    Jun 23
    Reported Aug 1
    		$-0.14$-0.14+0.00%Beat+44.0%
    Mar 23
    Reported May 2
    		$-0.17$-0.13-30.77%Miss+19.0%
    Dec 22
    Reported Mar 9
    		$-0.01N/A+93.33%Beat+95.2%
    Sep 22
    Reported Nov 3
    		$-0.28$-0.16-75.00%Miss-86.7%
    Jun 22
    Reported Aug 2
    		$-0.25$-0.12-108.33%Miss-127.3%
    Mar 22
    Reported May 3
    		$-0.21$-0.14-50.00%Miss-110.0%
    Dec 21
    Reported Mar 8
    		$-0.21$-0.13-61.54%Miss-2000.0%
    Sep 21
    Reported Nov 4
    		$-0.15$-0.12-25.00%Miss-650.0%
    Jun 21
    Reported Aug 3
    		$-0.11$-0.05-120.00%Miss-37.5%
    Mar 21
    Reported May 4
    		$-0.10$-0.05-100.00%Miss+0.0%
    Dec 20
    Reported Mar 9
    		$-0.01N/A+75.00%Beat+91.7%
    Sep 20
    Reported Nov 4
    		$-0.02N/A+77.78%Beat+90.5%
    Jun 20
    Reported Aug 4
    		$-0.08$-0.09+11.11%Beat+27.3%
    Mar 20
    Reported May 5
    		$-0.10$-0.15+33.33%Beat+33.3%
    Dec 19
    Reported Mar 5
    		$-0.12$-0.16+25.00%Beat+29.4%
    Sep 19
    Reported Nov 5
    		$-0.21$-0.14-50.00%Miss-110.0%
    Jun 19
    Reported Aug 6
    		$-0.11$-0.14+21.43%Beat+42.1%
    Mar 19
    Reported May 7
    		$-0.15$-0.18+16.67%Beat-50.0%
    Dec 18
    Reported Mar 7
    		$-0.17$-0.13-30.77%Miss-54.5%
    Sep 18
    Reported Nov 6
    		$-0.10$-0.14+28.57%Beat-42.9%
    Jun 18
    Reported Aug 2
    		$-0.19$-0.13-46.15%Miss-375.0%
    Mar 18
    Reported May 8
    		$-0.10$-0.13+23.08%Beat-100.0%
    Dec 17
    Reported Mar 8
    		$-0.11$-0.09-22.22%Miss+35.3%
    Sep 17
    Reported Nov 9
    		$-0.07$-0.07+0.00%Beat-
    Jun 17
    Reported Aug 7
    		$-0.04$-0.06+33.33%Beat-
    Mar 17
    Reported May 8
    		$-0.05$-0.10+50.00%Beat-
    Dec 16
    Reported Mar 3
    		$-0.17$-0.09-88.89%Miss-

    Key Metrics

    Valuation
    P/E Ratio-0.52EV/EBITDAN/A
    Price/FCF-1.01xFCF Yield-98.68%
    Profitability
    Profit Margin-48.90%Operating Margin-24.60%
    ROE-336.20%ROIC-74.25%
    Financial Health
    Debt/Equity-22.96xInterest CoverageN/A
    Current Ratio0.66xQuick Ratio0.50x
    Trading Statistics
    Beta1.37Avg Volume10.86K
    52-Week High$18.4052-Week Low$3.42

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.65
    SMA 20$4.14
    SMA 50$5.81
    SMA 200$9.96
    EMA 10$3.61
    EMA 20$4.18
    EMA 50$5.46
    EMA 200$9.47

    MACD

    Line: -0.76Signal: -0.74Hist: -0.02

    ADX

    ADX: 19.7+DI: 7.5-DI: 13.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$5.05

    Bollinger Bands

    Upper Band$5.61
    Lower Band$2.67
    %B Position7092%(Upper)
    Band Width0.11

    RSI (14-Day)

    Oversold
    19.1

    Momentum Oscillators

    Stoch %K6.1
    Stoch %D5.4
    Williams %R-90.7
    ROC (10d)-28.3%
    Momentum-1.19
    CCI (20d)-146.3
    MFI (14d)22.1

    Volatility Measures

    ATR (14d)$1.23(41.0%)
    StdDev (20d)0.73
    Hist Vol71.0%(High)

    Volume Flow

    VWAP$2.98
    OBV8.8M
    AD Line20.5B
    CMF (20d)-0.352

    Volume Metrics

    Avg Vol (20d)11.5K
    Vol Ratio0.9x
    VWMA (20d)$4.11

    Pivot Points

    R3$3.88
    R2$3.67
    R1$3.38
    Pivot Point$3.17
    S1$2.88
    S2$2.67
    S3$2.38

    Advanced Oscillators

    TSI-52.18
    Ultimate Osc35.1
    KST-404.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$9.63M$8.86M$9.23M$9.48M$9.62M$8.73M$9.15M$8.61M$8.84M$8.99M$3.40M$8.81M
    Cost of Revenue$2.58M$2.73M$2.43M$2.82M$2.80M$2.52M$2.90M$3.36M$2.34M$2.12M$-1,468,705$3.20M
    Gross Profit$7.05M$6.13M$6.80M$6.67M$6.81M$6.21M$6.25M$5.26M$6.50M$6.87M$4.87M$5.61M
    Operating Expenses$9.69M$9.17M$11.19M$9.53M$10.43M$10.10M$9.65M$10.09M$10.07M$11.53M$15.02M$12.96M
    R&D$1.45M$1.02M$1.24M$918,000$1.26M$1.66M$2.02M$1.83M$1.52M$2.25M$3.96M$3.75M
    SG&A$7.96M$8.15M$9.44M$8.61M$9.17M$8.43M$7.63M$8.26M$8.55M$9.28M$11.06M$9.21M
    Operating Income$-2,638,000$-3,044,000$-4,384,792$-2,862,000$-3,615,000$-3,888,000$-3,395,632$-4,830,000$-3,570,000$-4,656,368$-10,147,589$-7,350,198
    Interest Income$-868,000$-857,000$-745,866$-645,000$-616,000$-605,000$-624,347$-588,000$-180,000$-6,653$-52,230$-33,670
    Interest Expense$1.78M$2.08M$1.11M$709,000$0$0$5.86M$0$724,000$1.43M$0$1.84M
    Income Before Tax$-4,417,000$-5,129,000$-5,496,642$-3,571,000$1.95M$-1,479,000$-9,259,289$-2,768,000$-4,294,000$-6,088,711$-7,388,012$-9,193,520
    Income Tax Expense$0$0$0$-401,000$0$0$0$0$0$0$0$0
    Net Income$-4,417,000$-5,129,000$-5,496,642$-3,170,000$1.95M$-1,479,000$-7,568,289$-2,768,000$-4,294,000$-6,088,711$-6,574,273$-9,193,520
    EBITDA$-2,891,000$-3,605,000$-4,116,776$-2,335,000$3.19M$-279,000$-8,018,942$-1,561,000$-3,667,213$-5,638,845$-6,546,478$-8,697,202
    EBIT$-3,549,000$-4,272,000$-4,750,776$-2,926,000$2.56M$-874,000$-8,634,942$-2,180,000$-4,114,000$-6,082,058$-7,335,782$-9,159,850
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CTSO

    News

    Cytosorbents Corporation (CTSO) Stock Price, News, Quote & History

    This article provides detailed financial information for Cytosorbents Corporation (CTSO), including its current stock price, historical data, key statistics...

    Yahoo! Finance Canada•9/30/26•Neutral

    CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care

    CytoSorbents Corporation announced upcoming data presentations at major international conferences: the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Intensive Care Medicine (ESICM)...

    PR Newswire•9/30/26•Bullish

    Cytosorbents Corporation (CTSO) stock price, news, quote and history

    Cytosorbents Corporation (CTSO) stock information, including its current price of $4.38, recent performance, and key financial metrics, is provided. The company specializes in medical devices for blood purification...

    Yahoo Finance UK•9/24/26•Neutral

    CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement

    CytoSorbents Corporation announced it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement of $1.00 per share...

    PR Newswire•9/23/26•Bullish

    CytoSorbents regains Nasdaq $1.00 minimum bid compliance; MVLS shortfall remains under review

    CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement. However, the company remains noncompliant with the Nasdaq Market Value of Listed Securities (MVLS) $35 million requirement and has...

    TradingView•9/23/26•Neutral

    CTSO Valuation and Fair Value

    P/E
    -0.5x
    Forward P/E
    7.2x
    P/FCF
    -1.0x
    PEG
    0.0x
    P/B
    -12.5x
    See GNG's fair value

    CTSO Profitability: Margins, ROIC and FCF

    Gross margin
    71.6%
    Operating margin
    -24.6%
    Net margin
    -48.9%
    ROIC
    -74.2%
    ROE
    -336.2%
    FCF margin
    -25.0%
    FCF yield
    -98.7%

    CTSO Competitors

    CompanyTicker
    Phio Pharmaceuticals CorpPHIO
    NLS Pharmaceutics AGNLSP
    Ensysce Biosciences IncENSC
    CytoMed Therapeutics Limited Ordinary SharesGDTC
    Kiora Pharmaceuticals IncKPRX
    Biovie IncBIVI
    Alaunos Therapeutics IncTCRT
    Lantern Pharma IncLTRN

    Sector: Healthcare

    CTSO Bull Case vs Bear Case

    Bear case

    • CTSO has a -48.9% net profit margin.
    • CTSO beat EPS estimates in 25.0% of its last 8 reported quarters.

    CTSO Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -37.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.90
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    Frequently Asked Questions About CTSO

    Does CTSO pay dividends?

    Cytosorbents Crp (CTSO) does not currently pay a regular dividend.

    What is CTSO's market cap?

    Cytosorbents Crp (CTSO) has a market capitalization of $10.90M with a current stock price of $3.00.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In